Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
AthemBio logo — Turning Bioprocessing Complexity into Simplicity & Challenge...

AthemBio

Turning Bioprocessing Complexity into Simplicity & Challenges into Solutions.

Founded 2019 United States Durham, United States 5 employees Grant Total: $260.94K Biotechnology, Health and Wellness +1

General Information

Company Name AthemBio
Founded Year 2019
Location United States Durham, United States
Employees 5
Industries Biotechnology, Health and Wellness, Medical Devices
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with AthemBio. To contact AthemBio, visit athembio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AthemBio compare?

A PDF of AthemBio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AthemBio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AthemBio

AthemBio Analysis:

Name: AthemBio

Slogan: Turning Bioprocessing Complexity into Simplicity & Challenges into Solutions.

Description: AthemBio, founded in 2019, is a privately held company based in RTP NC, United States. It specializes in inventing breakthrough bioprocessing technologies and transforming them into solutions to solve major bioprocessing challenges. The company has a strong focus on working with global customers, gaining first-hand knowledge of challenges, and learning from past mistakes and successes. AthemBio aims to provide simple, scalable, robust, and automated solutions within the Biotechnology industry.

Last Investment: AthemBio secured a $5.00K grant investment on 10 August 2022.

Last Investment Investors: The investment was led by First Flight Venture Center.

Overall, AthemBio is positioned to make significant strides within the biotechnology sector with its innovative approach to addressing bioprocessing challenges.

Taxonomy: Bioprocessing, Vaccines, Cell Therapy, Antibodies, Innovation, Technology, Solutions, Robust, Automated, RTP NC, Global, Scalable, Complexity, Challenges

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $5.00K 1
First Flight Venture Center
First Flight Venture Center
10 Aug 2022
Grant $255.94K 1
National Science Foundation
National Science Foundation
09 Feb 2021

AthemBio Alternatives & Competitors

View All Alternatives
AthemBio vs
Agenus
Agenus United States

Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehe...

Post-IPO Debt
291 employees
Biotechnology, Health and Wellness
AthemBio vs
MicrofluidX
MicrofluidX

Addressing the challenges of process control, scalability, and affordability in cell bioprocessing,...

Seed
Biotechnology, Health Care
AthemBio vs
神州细胞工程有限公司
神州细胞工程有限公司

Pioneering accessible and affordable biological medicines through advanced protein and antibody tech...

Series A
91 employees
Biotechnology, Health Care
View all alternatives

FAQ About AthemBio

Turning Bioprocessing Complexity into Simplicity & Challenges into Solutions.
AthemBio was founded in 2019.
AthemBio is headquartered in Durham, United States.
AthemBio operates in Biotechnology, Health and Wellness and Medical Devices. Its work centres on Bioprocessing, Vaccines, Cell Therapy and Antibodies.
AthemBio has approximately 5 employees.
AthemBio has completed 2 funding rounds, raising a total of $260.94K. The latest funding stage is Grant.
Top alternatives and competitors to AthemBio include Agenus, MicrofluidX, 神州细胞工程有限公司, Membio Inc., MaxCyte, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AthemBio and Agenus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AthemBio, https://bouncewatch.com/company/athembio, updated 13 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes